Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matilde Sinibaldi

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Current Hematologic Malignancy Reports|January 25, 2017
T Cell-Depleted and T Cell-Replete HLA-Haploidentical Stem Cell Transplantation for Non-malignant DisordersAlice Bertaina, Angela Pitisci, Matilde Sinibaldi, et al.
Immunology Letters|May 11, 2013
Why do we need IgM memory B cells?Federica Capolunghi, M Manuela Rosado, Matilde Sinibaldi, et al.
Cells|June 24, 2022
T-Cell Defects Associated to Lack of Spike-Specific Antibodies after BNT162b2 Full Immunization Followed by a Booster Dose in Patients with Common Variable Immune DeficienciesFederica Pulvirenti, Stefano Di Cecca, Matilde Sinibaldi, et al.
Journal of Hematology & Oncology|November 13, 2021
Polymorphonuclear myeloid-derived suppressor cells impair the anti-tumor efficacy of GD2.CAR T-cells in patients with neuroblastomaNicola Tumino, Gerrit Weber, Francesca Besi, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 26, 2024
Autologous CD19-Targeting CAR T Cells in a Patient With Refractory Juvenile DermatomyositisRebecca Nicolai, Pietro Merli, Patricia Moran Alvarez, et al.
Frontiers in Immunology|June 2, 2020
Immune Modulation Properties of Zoledronic Acid on TcRγδ T-Lymphocytes After TcRαβ/CD19-Depleted Haploidentical Stem Cell Transplantation: An analysis on 46 Pediatric Patients Affected by Acute LeukemiaPietro Merli, Mattia Algeri, Federica Galaverna, et al.
Oncoimmunology|June 7, 2018
Choice of costimulatory domains and of cytokines determines CAR T-cell activity in neuroblastomaConcetta Quintarelli, Domenico Orlando, Iolanda Boffa, et al.
Frontiers in Immunology|November 5, 2021
Inclusion of the Inducible Caspase 9 Suicide Gene in CAR Construct Increases Safety of CAR.CD19 T Cell Therapy in B-Cell MalignanciesMarika Guercio, Simona Manni, Iolanda Boffa, et al.
Cancer Research|April 5, 2018
Adoptive Immunotherapy Using PRAME-Specific T Cells in MedulloblastomaDomenico Orlando, Evelina Miele, Biagio De Angelis, et al.
Blood Advances|June 25, 2025
Point-of-care fresh CAR T cells for pediatric or young adult BCP-ALL that is relapsed/refractory or in very-high-risk first relapseFrancesca Del Bufalo, Marco Becilli, Chiara Rosignoli, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Current Hematologic Malignancy Reports|January 25, 2017
T Cell-Depleted and T Cell-Replete HLA-Haploidentical Stem Cell Transplantation for Non-malignant DisordersAlice Bertaina, Angela Pitisci, Matilde Sinibaldi, et al.
Immunology Letters|May 11, 2013
Why do we need IgM memory B cells?Federica Capolunghi, M Manuela Rosado, Matilde Sinibaldi, et al.
Cells|June 24, 2022
T-Cell Defects Associated to Lack of Spike-Specific Antibodies after BNT162b2 Full Immunization Followed by a Booster Dose in Patients with Common Variable Immune DeficienciesFederica Pulvirenti, Stefano Di Cecca, Matilde Sinibaldi, et al.
Journal of Hematology & Oncology|November 13, 2021
Polymorphonuclear myeloid-derived suppressor cells impair the anti-tumor efficacy of GD2.CAR T-cells in patients with neuroblastomaNicola Tumino, Gerrit Weber, Francesca Besi, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 26, 2024
Autologous CD19-Targeting CAR T Cells in a Patient With Refractory Juvenile DermatomyositisRebecca Nicolai, Pietro Merli, Patricia Moran Alvarez, et al.
Frontiers in Immunology|June 2, 2020
Immune Modulation Properties of Zoledronic Acid on TcRγδ T-Lymphocytes After TcRαβ/CD19-Depleted Haploidentical Stem Cell Transplantation: An analysis on 46 Pediatric Patients Affected by Acute LeukemiaPietro Merli, Mattia Algeri, Federica Galaverna, et al.
Oncoimmunology|June 7, 2018
Choice of costimulatory domains and of cytokines determines CAR T-cell activity in neuroblastomaConcetta Quintarelli, Domenico Orlando, Iolanda Boffa, et al.
Frontiers in Immunology|November 5, 2021
Inclusion of the Inducible Caspase 9 Suicide Gene in CAR Construct Increases Safety of CAR.CD19 T Cell Therapy in B-Cell MalignanciesMarika Guercio, Simona Manni, Iolanda Boffa, et al.
Cancer Research|April 5, 2018
Adoptive Immunotherapy Using PRAME-Specific T Cells in MedulloblastomaDomenico Orlando, Evelina Miele, Biagio De Angelis, et al.
Blood Advances|June 25, 2025
Point-of-care fresh CAR T cells for pediatric or young adult BCP-ALL that is relapsed/refractory or in very-high-risk first relapseFrancesca Del Bufalo, Marco Becilli, Chiara Rosignoli, et al.
Pageof 3